Credit Suisse’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-14,900
Closed -$2.85M 4360
2019
Q4
$2.85M Hold
14,900
﹤0.01% 2329
2019
Q3
$2.51M Hold
14,900
﹤0.01% 2303
2019
Q2
$2.5M Buy
+14,900
New +$2.06M ﹤0.01% 2290
2018
Q4
Sell
-15,000
Closed -$2.86M 4070
2018
Q3
$2.86M Sell
15,000
-25,000
-63% -$4.59M ﹤0.01% 2091
2018
Q2
$6.67M Buy
+40,000
New +$6.42M 0.01% 1528
2018
Q1
Sell
-100,000
Closed -$16.4M 4210
2017
Q4
$16.4M Sell
100,000
-10,000
-9% -$1.79M 0.01% 988
2017
Q3
$22.5M Sell
110,000
-26,200
-19% -$6.09M 0.02% 764
2017
Q2
$33.1M Sell
136,200
-23,800
-15% -$5.59M 0.03% 559
2017
Q1
$38.2M Buy
+160,000
New +$37.3M 0.03% 528
2016
Q3
Sell
-13,500
Closed -$3.12M 4332
2016
Q2
$3.12M Buy
+13,500
New +$3.11M ﹤0.01% 2012
2015
Q2
Sell
-20,000
Closed -$5.95M 4693
2015
Q1
$5.95M Buy
+20,000
New +$5.7M 0.01% 1531

Other funds holding AGN

Credit Suisse's AGN Position: Q2 2020 in Review

Credit Suisse sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 10,733,794 shares — an estimated $1.9B sold.

Credit Suisse first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $1.9B in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Credit Suisse reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Credit Suisse sold 10,733,794 Allergan plc shares in Q2 2020, an estimated $1.9B.
  • Credit Suisse first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
  • Credit Suisse's Allergan plc position peaked at $1.9B in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Credit Suisse's 13F filing for Q2 2020, filed 12 Aug 2020.